Follow this link: Press release: New Phase 3 data presented at WORLDSymposium™ reinforce Nexviazyme® (avalglucosidase alfa) as potential new standard of care for all...
See original here: ALTUVIIIO™ approved by the U.S. FDA: this positive event triggers impairment reversal, positively impacting 2022 IFRS net income; no change on...
Read the original here: Bavarian Nordic to Host Full Year 2022 Results Conference Call
More: COMPASS Pathways plc to announce fourth quarter and year-end 2022 financial results on 28 February 2023
Read the original: TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Read the original: ARCA biopharma Announces 2022 Financial Results and Provides Corporate Update
Read this article: Financière de Tubize - Annual Report 2022
Pioneering Stem Cell Research Conference at The Aga Khan ...
Research Associate in Cancer Stem Cell Research job with ...
Recent Comments